Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990 –2011

ConclusionrMBC incidence declined over time with decreased HER2-positive distant recurrence, a shift to more triple-negative BC and consistently poor distant disease survival.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research